HALO logo
halo search icon
Design Therapeutics, Inc.
Design Therapeutics, Inc.
DSGN · NAS

Design Therapeutics, Inc.

US$11.10

Price Arrow0.61 (5.82%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Price MomentumRecent Price upgradeVolume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Design Therapeutics, Inc. Overview

DSGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About DSGN

icon

Website

Design Therapeutics, Inc.

icon

Telephone

1.858.293.4900

icon

Address

Suite 110, 6005 Hidden Valley Road, Carlsbad, CA 92011

Description

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

DSGN Price Chart

Key Stats

Market Cap

US$655.17M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.33 - 17.25

Trade Value (12mth)

US$762,109.00

1 week

-27%

1 month

-21.07%

YTD

15.27%

1 year

191.39%

All time high

50.50

Key Fundamentals

EPS 3 yr Growth

7.10%

EBITDA Margin

0.00%

Operating Cashflow

-$54m

Free Cash Flow Return

-23.80%

ROIC

-30.60%

Interest Coverage

0.00

Quick Ratio

17.10

Other Data

Shares Outstanding (Fully Diluted)

61m

HALO Sector

Healthcare

Next Company Report Date

15-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

DSGN Announcements

Latest Announcements

DateAnnouncements
18 May 26
18 May 26
29 April 26
29 April 26
02 April 26

DSGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.19-0.88-1.22locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.19-0.88-1.22locklocklock
Growth
%locklocklocklock-5.126.6-38.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Design Therapeutics, Inc. (DSGN:NAS)?
Halo FAQ
The current share price of Design Therapeutics, Inc. (DSGN:NAS) is USD$11.10.
What is the 52-week high share price for Design Therapeutics, Inc. (DSGN:NAS)?
Halo FAQ
The 52-week high share price for Design Therapeutics, Inc. (DSGN:NAS) is USD$17.25.
What is the 52-week low share price for Design Therapeutics, Inc. (DSGN:NAS)?
Halo FAQ
The 52-week low share price for Design Therapeutics, Inc. (DSGN:NAS) is USD$3.33.
What is the dividend yield for Design Therapeutics, Inc. (DSGN:NAS)?
Halo FAQ
Design Therapeutics, Inc. (DSGN:NAS) does not pay a dividend.
What was Design Therapeutics, Inc. (DSGN:NAS) last dividend payment?
Halo FAQ
Design Therapeutics, Inc. (DSGN:NAS) does not pay a dividend.
What is the franking level for Design Therapeutics, Inc. (DSGN:NAS)?
Halo FAQ
Design Therapeutics, Inc. (DSGN:NAS) has a franking level of 0.00%.
In which sector is Design Therapeutics, Inc. (DSGN:NAS) classified?
Halo FAQ
Design Therapeutics, Inc. (DSGN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.